Covered recipient · General Payments record
KHATUNA GURGENASHVILI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,593.38
- Reported across 199 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $281.82 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $99.02 | 4 |
| Lilly USA, LLC | $52.22 | 3 |
| Amneal Pharmaceuticals LLC | $43.03 | 1 |
| ARGENX US, INC. | $41.20 | 2 |
| Genentech USA, Inc. | $24.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.11 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103854507 | CMS |
| ABBVIE INC. | $19.86 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103854509 | CMS |
| ABBVIE INC. | $18.20 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103854511 | CMS |
| ABBVIE INC. | $29.85 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103854513 | CMS |
| Amneal Pharmaceuticals LLC | $43.03 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139187896 | CMS |
| ARGENX US, INC. | $21.50 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142107999 | CMS |
| ARGENX US, INC. | $19.70 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118233 | CMS |
| Genentech USA, Inc. | $24.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133048485 | CMS |
| Lilly USA, LLC | $19.36 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135078783 | CMS |
| Lilly USA, LLC | $14.32 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135106051 | CMS |
| Lilly USA, LLC | $18.54 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135112412 | CMS |
| Novartis Pharmaceuticals Corporation | $21.78 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086875985 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.